Using Descemet's membrane to improve eye surface treatments
Ocular surface applications of Descemet's membrane
This study is looking at how to help people with vision loss from limbal stem cell deficiency by testing new ways to transplant healthy eye cells, making sure they have the best chance to grow and heal the cornea properly.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11088212 on NIH RePORTER |
What this research studies
This research focuses on addressing limbal stem cell (LSC) deficiency, a condition that leads to significant vision loss due to the failure of the cornea to regenerate properly. The approach involves transplanting cultured limbal epithelial cells to replace damaged cells in the eye, aiming to restore the corneal surface. The study seeks to enhance the success of these transplants by identifying supportive materials that can mimic the natural environment of the limbus, which is crucial for the health and function of stem cells. By improving the conditions under which these cells are transplanted, the research hopes to achieve better long-term outcomes for patients suffering from corneal blindness.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from limbal stem cell deficiency due to chemical injuries or autoimmune diseases.
Not a fit: Patients with corneal blindness caused by conditions unrelated to limbal stem cell deficiency may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for corneal blindness, significantly improving patients' vision and quality of life.
How similar studies have performed: Previous research has shown promising short-term success with similar cell transplantation approaches, although long-term outcomes remain a challenge.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Hou, Joshua H — University of Minnesota
- Study coordinator: Hou, Joshua H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.